China's Simcere to be taken private by Chairman for $495 mln
Aug 28 (Reuters) - China's Simcere Pharmaceutical Group said it agreed to be bought by a consortium that includes its founder-chairman Jinsheng Ren in a deal worth $495.4 million.
The company said it will receive $9.66 per American depositary share (ADS), representing a premium of about 3 percent over Tuesday's close on the New York Stock Exchange.
The consortium already owns about 78 percent of Simcere's outstanding shares and had made an offer worth $9.56 per ADS to buy the company on March 11.
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Canada PM vows crackdown after capital shocked by fatal attacks |
- Man arrested after jumping White House fence, causing lockdown
- Probe: Athletes took fake classes at University of North Carolina
- A Minute With: Shailene Woodley on teen sex, violence and Marvel